Orbitofrontal<sup><b>18</b></sup>F-DOPA Uptake and Movement Preparation in Parkinson’s Disease

Lucio Marinelli(Martin University), Flavio Nobili(Alleanza Contro il Cancro)

Parkinson s Disease

January 1, 2015

10.1155/2015/180940

Cited by 8

Related Papers

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

|The Lancet Neurology|2017|630

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

|The Lancet Neurology|2020|535

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials

|EClinicalMedicine|2023|60

Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration

|BMJ|2024|45

Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes

|Journal of Affective Disorders|2019|37